Issue Briefs

Reasonable and Fair Market Value of Medical Expenses

Reasonable and Fair Market Value of Medical Expenses 150 150 Avalon Health Economics LLC

Some time has passed since we began writing in Issue Briefs about the distinction between charged amounts, or prices, and reasonable, fair market value. In the field of economics, these distinctions generally don’t pose a problem, because prices tend to gravitate to fair market value. In other words, if I own a coffee shop and…

read more

Can the Total be Greater than the Sum of the Parts? Assessing Damages in Product Liability

Can the Total be Greater than the Sum of the Parts? Assessing Damages in Product Liability 150 150 Avalon Health Economics LLC

In product liability matters it is often the case that some harm or cost is alleged to have been caused, either directly, because of production or consumption of the product, or indirectly, in the form of a “negative externality.” But it is often the case that, distinct from any litigation, health economists and health researchers…

read more

Product Liability and “Socially Optimal” Outcomes: The Importance of the Analyzing Cost-Benefit Tradeoffs in Healthcare Products and Services

Product Liability and “Socially Optimal” Outcomes: The Importance of the Analyzing Cost-Benefit Tradeoffs in Healthcare Products and Services 150 150 Avalon Health Economics LLC

In some product liability cases, in addition to alleged damages, plaintiffs might argue that sales of a product or service should be limited. While there may be cases where such an outcome could be considered “first best” or “socially optimal” from an economics perspective, there are many cases for which limiting sales may not result…

read more

Attributable Risk and Attributable Fraction: Litigation Applications

Attributable Risk and Attributable Fraction: Litigation Applications 150 150 Avalon Health Economics LLC

In the fields of medicine and public health, we often ask the question “What part of Problem X is caused by Factor Y.” Specifically, we want to know the “fraction” of a problem that is caused by each of the possible (or theoretical) causal factors. Or simply, who or what is to blame, and by…

read more

What are “Hedonic Damages,” and Should They Matter in Litigation?

What are “Hedonic Damages,” and Should They Matter in Litigation? 150 150 Avalon Health Economics LLC

In recent years there has been a resurgence in what are called “hedonic damages,” especially in cases involving personal injury and product liability. The concept of hedonic damages is based on the calculation of the total estimated value of a human life (i.e., as might normally be calculated in a wrongful death case), “weighted” in…

read more

What Do Economists have to Say About Liability?

What Do Economists have to Say About Liability? 150 150 Avalon Health Economics LLC

Most are familiar with the economics subfield referred to as “Law and Economics.” The subfield of Law and Economics is where economic concepts are applied to (and overlap with) issues of public policy, regulation, contracts, environmental policy, health and safety policy, and related fields in which the specifics of laws and statutes have implications for…

read more

The Rise of Litigation Funding and Medical Funding in Personal Injury and Product Liability Lawsuits

The Rise of Litigation Funding and Medical Funding in Personal Injury and Product Liability Lawsuits 150 150 Avalon Health Economics LLC

Cases involving personal injury and product liability increasingly feature the use of third-party litigation financing, wherein a medical funding or medical financing company (referred to interchangeably hereafter as “MFCs”) has undertaken responsibility to pay providers for services rendered (i.e., post-incident but not including alleged future care). Although the specific structure and form of MFC arrangements…

read more

Analysis of Dental and Vision Plan Non-Covered Services and Materials Mandates and the Projected Role of the DOC Access Act in the Vision and Dental Markets: An Update

Analysis of Dental and Vision Plan Non-Covered Services and Materials Mandates and the Projected Role of the DOC Access Act in the Vision and Dental Markets: An Update 960 484 Avalon Health Economics LLC

In 2016, we conducted a survey-based study of optometry and dentistry in North Carolina and Texas to determine the impact on fees charged in states with laws prohibiting insurers from setting fees for non-covered services.

read more

Economic Evaluation and Market Access for Medical Devices in the U.S.: Implications of a U.S. Health Technology Assessment Agency

Economic Evaluation and Market Access for Medical Devices in the U.S.: Implications of a U.S. Health Technology Assessment Agency 860 484 Avalon Health Economics LLC

The Biden Administration has indicated an intent to explore the creation of a government-operated health technology assessment (HTA) agency to engage in some form of review of biopharmaceuticals and other medical technologies.

read more

Count the Cost of Disability Caused by COVID-19

Count the Cost of Disability Caused by COVID-19 860 484 Avalon Health Economics LLC

Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies. The COVID-19 pandemic is well into its second year, but countries are only beginning to grapple with the lasting health crisis.

read more
Loading...